Epigenetic signatures that differentiate triple-negative breast cancers

2 febrero 2015

Epigenetic ‘signatures’ have been identified that could help clinicians tell the difference between highly aggressive and more benign forms of triple-negative breast cancer. The study reveals «distinct methylation patterns» in the primary biopsy breast cancer cells indicating better or worse prognosis.